time to see some action!

ok, we have had a cap raising that all seems like a white elephant due to the fact that we had one this time last year that was supposed to be the be all and end all. At that time there was an oversubscription....- result, They decided to still scale it back in fear of dilution. Meanwhile the SP is kept real at around the price of the CR. Who and why would buy spp?, at market price? Where is the incentive?

A wishy washy announcement was made recently about the posibilty of some sales but there was no concrete detail so we are still left in the dark,

The old machine was shut down to be moved into the new big joint, only to see more delay in production while the new FDA approval is sought.

The wait continues.... there will be no reason to buy in at these exorbitant prices unless we get concrete sales or deals signed by new pharmas, even then, we cant supply profitable quantities till we get the new line that can pump 150m+ units.

Spec hold IMO.